SciSparc Secures Strategic Advantage with Grant of European Patent TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...

Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination Metuchen, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Feutune Light Acquisition Corporation (NASDAQ: FLFV) (the “Company”), a blank check company incorporated as a Delaware corporation, today announced...